Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
62,124,648
-
Total 13F shares
-
50,234,935
-
Share change
-
-1,519,014
-
Total reported value
-
$273,791,080
-
Price per share
-
$5.45
-
Number of holders
-
116
-
Value change
-
-$8,935,762
-
Number of buys
-
50
-
Number of sells
-
46
Institutional Holders of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) as of Q4 2025
As of 31 Dec 2025,
Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,234,935 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, Frazier Life Sciences Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., Long Focus Capital Management, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Medicxi Ventures Management (Jersey) Ltd, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, and Nantahala Capital Management, LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.